Design, synthesis, and biological evaluation of novel halogenated chlorido[N,N′-bis(salicylidene)-1,2-bis(3-methoxyphenyl)ethylenediamine]iron(III) complexes as anticancer agents
JBIC Journal of Biological Inorganic Chemistry · 2024
DOI: 10.1007/s00775-024-02067-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift JBIC Journal of Biological Inorganic Chemistry, 2024. Verfasst von Astrid Dagmar Bernkop-Schnürch und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI-Center for Molecular Biosciences Innsbruck, CCB-Center for Chemistry and Biomedic…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Halogenation, Drug Design, Coordination Complexes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Austrian Science Fund, University of Innsbruck and Medical University of Innsbruck.
Abstract (Originalsprache)
Iron(III) complexes based on N,N ´-bis(salicylidene)ethylenediamine (salene) scaffolds have demonstrated promising anticancer features like induction of ferroptosis, an iron dependent cell death. Since poor cellular uptake limits their therapeutical potential, this study aimed to enhance the lipophilic character of chlorido[ N,N ′-bis(salicylidene)-1,2-bis(3-methoxyphenyl)ethylenediamine]iron(III) complexes by introducing lipophilicity improving ligands such as fluorine ( X1 ), chlorine ( X2 ) and bromine ( X3 ) in 5-position in the salicylidene moieties. After detailed characterization the binding to nucleophiles, logP values and cellular uptake were determined. The complexes were further evaluated regarding their biological activity on MDA-MB 231 mammary carcinoma, the non-tumorous SV-80 fibroblast, HS-5 stroma and MCF-10A mammary gland cell lines. Stability of the complexes in aqueous and biological environments was proven by the lack of interactions with amino acids and glutathione. Cellular uptake was positively correlated with the logP values, indicating that higher lipophilicity enhanced cellular uptake. The complexes induced strong antiproliferative and antimetabolic effects on MDA-MB 231 cells, but were inactive on all non-malignant cells tested. Generation of mitochondrial reactive oxygen species, increase of lipid peroxidation and induction of both ferroptosis and necroptosis were identified as mechanisms of action. In conclusion, halogenation of chlorido[ N,N ′-bis(salicylidene)-1,2-bis(3-methoxyphenyl)ethylenediamine]iron(III) complexes raises their lipophilic character resulting in improved cellular uptake. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Institute of Pharmacy, CMBI-Center for Molecular Biosciences Innsbruck, CCB-Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.
- Immunobiology and Stem Cell Laboratory, Department of Internal Medicine V (Hematology and Oncology), Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.
- Department of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.
- Biocenter, Institute of Medical Biochemistry, Protein Core Facility, Medical University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.
- Department of Anesthesiology and Critical Care Medicine, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.
- Immunobiology and Stem Cell Laboratory, Department of Internal Medicine V (Hematology and Oncology), Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria. brigitte.kircher@i-med.ac.at.
ORCID-Profile: Astrid Dagmar Bernkop-Schnürch, Brigitte Kircher
Förderung
- Austrian Science Fund FWF
- Austrian Science Fund
- University of Innsbruck and Medical University of Innsbruck
Zitieren
APA
Bernkop-Schnürch, A. D., Huber, K., Clauser, A., Cziferszky, M., Leitner, D., Talasz, H., Hermann, M., Hohloch, S., Gust, R., & Kircher, B. (2024). Design, synthesis, and biological evaluation of novel halogenated chlorido[N,N′-bis(salicylidene)-1,2-bis(3-methoxyphenyl)ethylenediamine]iron(III) complexes as anticancer agents. JBIC Journal of Biological Inorganic Chemistry. https://doi.org/10.1007/s00775-024-02067-9
Vancouver
Bernkop-Schnürch AD, Huber K, Clauser A, Cziferszky M, Leitner D, Talasz H, et al. Design, synthesis, and biological evaluation of novel halogenated chlorido[N,N′-bis(salicylidene)-1,2-bis(3-methoxyphenyl)ethylenediamine]iron(III) complexes as anticancer agents. JBIC Journal of Biological Inorganic Chemistry. 2024. doi:10.1007/s00775-024-02067-9
BibTeX
@article{BernkopSchnrch2024,
author = {Bernkop-Schnürch, Astrid Dagmar and Huber, Klaus and Clauser, Armida and Cziferszky, Monika and Leitner, Daniel and Talasz, Heribert and Hermann, Martin and Hohloch, Stephan and Gust, Ronald and Kircher, Brigitte},
title = {Design, synthesis, and biological evaluation of novel halogenated chlorido[N,N′-bis(salicylidene)-1,2-bis(3-methoxyphenyl)ethylenediamine]iron(III) complexes as anticancer agents},
journal = {JBIC Journal of Biological Inorganic Chemistry},
year = {2024},
doi = {10.1007/s00775-024-02067-9}
}
EUVIMED